Study of Inactivity on Metabolism of Elderly Muscles

Sponsor
McMaster University (Other)
Overall Status
Completed
CT.gov ID
NCT01818609
Collaborator
(none)
10
1
1
15
0.7

Study Details

Study Description

Brief Summary

Skeletal muscle mass declines with inactivity (casting is a good example) and increases with activity (such as weightlifting). Whether muscle mass increases or decreases, is determined by whether more new proteins within muscle are made than are broken down. The investigators know that feeding protein increases the synthesis of new proteins but that the response of older muscles to protein feeding is blunted compared with the young. This resistance of the elderly to muscle building stimuli may be the primary reason that muscle mass is lost in aging. The investigators also know that periods of muscle disuse such as casting result in a person's muscle shrinking due, the investigators believe, to a lower rate of synthesis of new muscle proteins. Age-related muscle loss begins around 50 years old and proceeds at approximately 1% for every year after. Elderly persons would likely fare well with advancing age if their muscle loss were simply linear; however, a rate of muscle loss of 1% annually is a 'population view' and does not represent what occurs during short periods of muscle disuse (i.e. during hospitalization or illness), which occur with increasing frequency in elderly persons. During periods of disuse, the resistance of elderly muscles to protein nutrition may be worsened. The investigators will measure how quickly new proteins are made at rest and after protein feeding in elderly men, before and after a 14 day period of reduced activity brought on by having people reduce their daily step count.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Step reduction
Phase 1

Study Design

Study Type:
Interventional
Actual Enrollment :
10 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Influence of Reduce Daily Step Count on Muscle Protein Metabolism in Older Persons
Study Start Date :
Sep 1, 2011
Actual Primary Completion Date :
Sep 1, 2012
Actual Study Completion Date :
Dec 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: Step Reduction

Step reduction: Take less than 1500 steps/d No disease

Behavioral: Step reduction
taking less than 1500 steps/d
Other Names:
  • Sedentary behaviour
  • Outcome Measures

    Primary Outcome Measures

    1. Fractional synthetic rate (FSR) of myofibrillar muscle protein [over 5h]

      rate of making new muscle proteins

    Secondary Outcome Measures

    1. Blood amino acid concentrations [over 5h]

      concentration of amino acids in blood

    2. Intramuscular signalling protein status [over 5h]

      phosphorylation of key signalling proteins

    3. Insulin sensitivity via blood sampling [over 5h]

      measure of insulin concentration

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    60 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Male or Female

    • Aged 60 to 80 years old

    • Non-smoker Generally healthy and can tolerate the resistance exercise and protein drink

    Exclusion Criteria:
    • Allergies to whey protein

    • Health problems such as: heart disease, rheumatoid arthritis of the knee joint, diabetes, poor lung function, uncontrolled hypertension, or any health conditions that might put participants at risks for this study

    • Failed an exercise stress test

    • Taking metformin and/or other medications for the control of blood glucose even though one might not be classified as diabetic

    • Taking prescribed blood thinners such as warfarin and heparin but excluding aspirin

    • Taking medications for lung and kidney conditions but excluding medication for asthma that is under control

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 McMaster University Hamilton Ontario Canada L8S 4K1

    Sponsors and Collaborators

    • McMaster University

    Investigators

    • Principal Investigator: Stuart M Phillips, PhD, McMaster University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    McMaster University
    ClinicalTrials.gov Identifier:
    NCT01818609
    Other Study ID Numbers:
    • 267
    First Posted:
    Mar 26, 2013
    Last Update Posted:
    Feb 25, 2020
    Last Verified:
    Mar 1, 2013

    Study Results

    No Results Posted as of Feb 25, 2020